Powder: -20°C for 3 years | In solvent: -80°C for 2 years
NBI-921352 is a blocker of Sodium Channel protein type 8 subunit alpha and can be used in studies about nervous system pathologies of epilepsy treatment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 119.00 | |
2 mg | In stock | $ 176.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 488.00 | |
25 mg | In stock | $ 785.00 | |
50 mg | In stock | $ 1,120.00 | |
100 mg | In stock | $ 1,480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 327.00 |
Description | NBI-921352 is a blocker of sodium channel protein type 8 subunit alpha and can be used in studies about nervous system pathologies of epilepsy treatment. |
Synonyms | XEN901, NBI-921352 |
Molecular Weight | 460.59 |
Formula | C22H25FN4O2S2 |
CAS No. | 2154406-04-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 112.5mg/mL (244.3mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zandatrigine 2154406-04-7 Membrane transporter/Ion channel Sodium Channel XEN901 NBI-921352 inhibitor inhibit